top of page
Screenshot 2025-05-29 at 12.38.16 PM.png

Monica Errico, PhD

Executive Director - Healthcare (Biotech & Medtech)

  • Linkedin

Monica is apart of TimeX's BioTech & MedTech sector of Healthcare, applying her extensive scientific and commercial expertise to support clients in translating innovation into impact. She plays a central role in shaping TimeX’s approach to life sciences advisory, ensuring that early-stage ventures receive strategic guidance that aligns scientific rigor with business execution.

 

A biologist with a background in Immunology and Infectious Disease with over 25 years of industry experience and a proven track record in commercials strategy and execution for life science discovery tools, services, and diagnostics companies, as well as medical devices, she is a co-founder, Managing Director; CSO at Apollo Biomedical Solutions LLC.


Monica began her career in high-throughput, translational, and clinical emerging technology development at Janssen and Sanofi (formerly Aventis) Pharmaceuticals before moving into commercial positions within life science tools and Medtech startups. As Managing Partner at Apollo Biomedical Solutions, Monica oversees the day-to-day operations of the advisory firm, specializing in market research, strategic planning, operational efficiency, and commercial execution for early-stage life science tools, services, RUO diagnostic companies, as well as medical devices and medical diagnostics. The firm’s advisory specializes in working with high-risk companies early stage companies that have struggled in seed series A and B raises due to operations and commercial challenges.

​

Monica is a judge, mentor, and head of faculty for Biotools & Medtech Innovator for Commercial Strategy & Channel Execution, the largest global accelerator in the world solely focused on Medtech and life sciences. Monica is also a Subject Matter Expert (SME) and mentor for the Biomedical Advanced Research and Development Authority (BARDA) Vanguard Fund.


Monica earned a Bachelor of Science in Behavioral Psychology from Ramapo College of New Jersey, followed by a Ph.D. in Molecular Biosciences and a certificate in Entrepreneurship from Seton Hall University, as well as recently completed an eMBA in Mindfulness in Leadership from LinkedIn Learning, Sounds True.

​

Securities are offered through Finalis Securities LLC Member FINRA / SIPC.  TimeX Capital LLC is not a registered broker-dealer, and Finalis Securities LLC and TimeX Capital LLC are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.

Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck | Finalis Form Customer Relationship Summary (“Form CRS”)

timexcapital.com (the "TimeX Capital LLC Website") is a website operated by TimeX Capital LLC. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and TimeX Capital LLC along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.

Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis’ Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.

bottom of page